the aid library

LIST OPTIONS

Filter

5716

Sort by:

Direction:

Download (37)

View PDF (73)

Living - Skills for Life, Botswana’s Window of Hope

Education Development Center; Botswana Ministry of Education and Skills Development; et al. (2010) C2

Usage Guidelines Junior and Senior Secondary

Download (2275)

View PDF (5097)

Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection
recommended

World Health Organization WHO (2016) C_WHO

2nd edition. These guidelines provide guidance on the diagnosis of human immunodeficiency virus (HIV) infection, the use of antiretroviral (ARV) drugs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention,... more

Download (815)

View PDF (1254)

Sexual Reproductive Health of Women Living HIV/AIDS

World Health Organization; UNFPA (2006)

Guidelines on care, treatment and support for women living with HIV/AIDS and their children in resource-constrained settings

Download (100)

View PDF (167)

Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection - AIDSinfo

AIDSinfo (2019) C2

Downloaded from https://aidsinfo.nih.gov/guidelines on 10/19/2019 Developed by the HHS Panel on Antiretroviral Therapy and Medical Management of Children Living with HIV—A Working Group of the Office of AIDS Research Advisory Council (OARAC)

Download (867)

View PDF (1418)

National guidelines for nutrition care and support of People living with HIV
recommended

Tanzania Food and Nutrition Centre Ministry of Health, Tanzania (2016) C1

Download (292)

View PDF (412)

Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy

World Health Organization (WHO) (2017) C_WHO

The objectives of these guidelines are to provide recommendations outlining a public health approach to managing people presenting with advanced HIV disease, and to provide guidance on the timing of initiation of antiretroviral therapy (ART) for all people living with HIV.
WHO recommends that a... more

Download (188)

View PDF (259)

NATIONAL GUIDELINES FOR COMPREHENSIVE CARE OF PEOPLE LIVING WITH HIV IN RWANDA

Ministry of Health, Rwanda (2011) C2

This guide presents new knowledge and guidelines on the provision of care to persons living with HIV/AIDS, in accordance with the last guidelines of the World Health Organization (WHO) published in 2006 and adapted to the Rwandan national context. It thus responds to the need by the Ministry of Heal... more

Download (727)

View PDF (1201)

Operational Guidelines for Isoniazid Preventive Therapy for People Living with HIV

Ministry of Health, Kenya (2015) C1

Download (1029)

View PDF (761)

National guidelines for food and nutritional support and care for people living with HIV/AIDS

Ministry of Health, Rwanda (2014)

Accessed on March 2014

Download (980)

View PDF (1746)

Guidelines to Referral Health Care in Lebanon

UNHCR (2014)

The standard operating procedures (SOP) for referral care cover all the refugee populations living in Lebanon. These SOPs outline the policies and procedures for referral care in Lebanon, including the limits in health assistance that can be provided.

Download (448)

View PDF (954)

Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV
recommended

World Health Organization (WHO) (2022) C_WHO

Cryptococcal disease is one of the most common opportunistic infections among people living with advanced HIV disease and is a major contributor to severe illness, morbidity, and mortality, particularly in sub-Saharan Africa. These guidelines update the recommendations that were first released i... more

Download (320)

View PDF (551)

Operational Guidelines for Care & Support Centres India

National AIDSControl (NACO), Government of India; Ministry of Health and Family Welfare (2013) C1

Care and Support Centre (CSC) is a national initiative to provide expanded and holistic care and support services for PLHIV. The guideline focuses on the objectives, criteria for selection, required infrastructure, human resources, MIS tools, and financial guidelines for CSCs. This guideline will b... more

Download (641)

View PDF (1496)

HIV and adolescents: Guidance for HIV testing and counselling and care for adolescents living with HIV

World Health Organization (2013)

These guidelines provide specific recommendations and expert suggestions — for national policy-makers and programme managers and their partners and stakeholders— on prioritizing, planning and providing HIV testing, counselling, treatment and care services for adolescents

Download (118)

View PDF (162)

Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV
recommended

World Health Organization WHO (2020) C_WHO

Histoplasmosis is a disease caused by the fungus Histoplasma capsulatum. This disease is highly endemic in some regions of North America, Central America, and South America and is also reported in certain countries of Asia and Africa. It often affects people with impaired immunity, including people ... more

Download (311)

View PDF (268)

Guidelines: updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring
recommended

World Health Organization WHO (2021) C_WHO

These guidelines provide new and updated recommendations on the use of point-of-care testing in children under 18 months of age and point-of-care tests to monitor treatment in people living with HIV; the treatment monitoring algorithm; and timing of antiretroviral therapy (ART) among people living w... more

Download (205)

View PDF (237)

Updated Recommendations Onservice Delivery For The Treatment And Care Of People Living With HIV. Summary Slides
recommended

World Health Organization WHO (2021) C_WHO

Download (176)

View PDF (194)

Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV. Policy brief
recommended

World Health Organization WHO (2022) C_WHO

Cryptococcal disease, particularly cryptococcal meningitis is a significant cause of morbidity and mortality among people living with HIV with advanced HIV disease. It is estimated that it is responsible for nearly 19% of AIDS-related mortality, second only to tuberculosis. Rapid screening, diagnosi... more

Download (60)

View PDF (595)

MAGICapp

MAGIC Evidence Ecosystem Foundation (2022) CC

MAGIC authoring and publication platform (MAGICapp) - for guidelines and evidence summaries - is developed through our research and innovation program. The platform allows authors to write and publish their guidelines and evidence summaries in a highly structured fashion, using the GRADE methodol... more

Download (104)

View PDF (169)

Guidelines on mental health at work

World Health Organization WHO (2022) C_WHO

The WHO guidelines on mental health at work provide evidence-based recommendations to promote mental health, prevent mental health conditions, and enable people living with mental health conditions to participate and thrive in work. The recommendations cover organizational interventions, manager tra... more

Download (176)

View PDF (247)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Consolidated guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection recommended

National guidelines for nutrition care and support of People living with HIV recommended

Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV recommended

Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV recommended

Guidelines: updated recommendations on HIV prevention, infant diagnosis, antiretroviral initiation and monitoring recommended

Updated Recommendations Onservice Delivery For The Treatment And Care Of People Living With HIV. Summary Slides recommended

Guidelines for diagnosing, preventing and managing cryptococcal disease among adults, adolescents and children living with HIV. Policy brief recommended